Nir Naor

Nir Naor has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Axogen, Inc., Brainstorm Cell Therapeutics Inc. and Neuronetics, Inc. Between 19 June 2023 and 23 July 2026, the trades on record add up to 5 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The newest entry dates from 23 July 2026: a share grant, in Neuronetics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.